Drug · DIN 02480247
PMS-PROGESTERONE
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 31, 2024; first marketed February 7, 2019.
- Drug Identification Number (DIN)
- 02480247
- Company (DIN owner)
- Pharmascience Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Progesterone G03DA04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PROGESTERONE | 200 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 22, 2018: NOC 21236New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “pms-progesterone”. A notice may cover another product or only some lots: read it to see what it covers.
- One lot of pms-PROGESTERONE 100 mg capsules recalled because it may pose serious risks to individuals with severe peanut allergiesAugust 24, 2021 · Drugs
- PMS-PROGESTERONE (2021-08-20)August 20, 2021 · Drugs · Product safety · Type I
Other DINs named PMS-PROGESTERONE
- DIN 02476576 · Marketed